CYP26A1 and breast cancer: The mRNA levels of Cyp26a1, encoding an RA-inducible retinoid hydroxylase (38), were 3,000-fold and 15-fold higher in the VAS and BC groups, respectively, when compared with the VAD baseline group (Fig. 5G).